Skin toxicities associated with epidermal growth factor receptor inhibitors
作者： Tianhong Li , Roman Perez-Soler
DOI: 10.1007/S11523-009-0114-0
关键词:
摘要: The use of epidermal growth factor receptor (EGFR) inhibitors in several epithelial tumors has increased considerably in recent years. Currently, they are approved in non-small cell …
springer.com
elsevier.com
sci-hub.se 参考文章(76)
More on severe cutaneous reaction with radiotherapy and cetuximab [13] The New England Journal of Medicine. ,vol. 357, pp. 1872- 1873 ,(2007) , 10.1056/NEJMC076359
Mario E. Lacouture, Lynne I. Wagner, Dermatologic toxicities associated with EGFR inhibitors: the clinical psychologist's perspective. Impact on health-related quality of life and implications for clinical management of psychological sequelae. Oncology. ,vol. 21, pp. 34- 35 ,(2007)
R. Murillas, F. Larcher, C. J. Conti, M. Santos, A. Ullrich, J. L. Jorcano, Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure. The EMBO Journal. ,vol. 14, pp. 5216- 5223 ,(1995) , 10.1002/J.1460-2075.1995.TB00206.X
Horst Buerger, Frank Gebhardt, Hartmut Schmidt, Burkhard Brandt, Werner Boecker, Kirsten Hutmacher, Alf Beckmann, Ralph Lelle, Ronald Simon, Length and Loss of Heterozygosity of an Intron 1 Polymorphic Sequence of egfr Is Related to Cytogenetic Alterations and Epithelial Growth Factor Receptor Expression Cancer Research. ,vol. 60, pp. 854- 857 ,(2000)
Ulrich Rodeck, Monika Jost, Csaba Kari, The EGF receptor - an essential regulator of multiple epidermal functions. European Journal of Dermatology. ,vol. 10, pp. 505- 510 ,(2000)
Saveria Pastore, Francesca Mascia, Feliciana Mariotti, Cristina Dattilo, Valentina Mariani, Giampiero Girolomoni, ERK1/2 Regulates Epidermal Chemokine Expression and Skin Inflammation The Journal of Immunology. ,vol. 174, pp. 5047- 5056 ,(2005) , 10.4049/JIMMUNOL.174.8.5047
Siegfried Segaert, Josep Tabernero, Olivier Chosidow, Thomas Dirschka, Joern Elsner, Luca Mancini, Tim Maughan, Jean-Franuois Morere, Armando Santoro, Alberto Sobrero, Eric Van Cutsem, Alison Layton, The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies. Journal Der Deutschen Dermatologischen Gesellschaft. ,vol. 3, pp. 599- 606 ,(2005) , 10.1111/J.1610-0387.2005.05058.X
Brian Higgins, Kenneth Kolinsky, Melissa Smith, Gordon Beck, Mohammad Rashed, Violeta Adames, Michael Linn, Eric Wheeldon, Laurent Gand, Herbert Birnboeck, Gerhard Hoffmann, Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models. Anti-Cancer Drugs. ,vol. 15, pp. 503- 512 ,(2004) , 10.1097/01.CAD.0000127664.66472.60
Román Peréz-Soler, Leonard Saltz, Cutaneous adverse effects with HER1/EGFR-targeted agents: is there a silver lining? Journal of Clinical Oncology. ,vol. 23, pp. 5235- 5246 ,(2005) , 10.1200/JCO.2005.00.6916
Shigenori Kanazawa, Mikiko Muramatsu, Yoshimi Kinoshita, Kazuyuki Yamaguchi, Shosaku Nomura, Gefitinib Has the Potential of Activating Cell Immunity Against Malignant Cells Journal of Clinical Oncology. ,vol. 23, pp. 3865- 3866 ,(2005) , 10.1200/JCO.2005.05.148